Clinical Trials
3 trialsNCT06175273 2025-09-18
POINT
University of Kentucky
Phase 2/3 Completed
NCT03631004 2022-01-13
Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients
Instituto do Cancer do Estado de São Paulo
Phase 2/3 Completed
NCT03137121 2021-08-17
Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients
University of Alabama at Birmingham
Phase 2/3 Completed